Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics.
More Information Supplier PageRifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics.
More Information Supplier PageRifapentine is an antibiotic drug used in the treatment of tuberculosis.
More Information Supplier PageRifapentine is an antibiotic drug used in the treatment of tuberculosis.
More Information Supplier PageRifapentine is an antibiotic drug used in the treatment of tuberculosis.
More Information Supplier PageRifapentine is an antibiotic drug used in the treatment of tuberculosis.
More Information Supplier PageAntibiotic; inhibits bacterial RNA polymerase. Prototypical activator of the pregnane X receptor (PXR).
More Information Supplier PageRepaglinide is a potent short-acting insulin secretagogue that acts by closing ATP-sensitive potassium (KATP) channels in the plasma membrane of the pancreatic beta cell.
More Information Supplier PageRepaglinide is a potent short-acting insulin secretagogue that acts by closing ATP-sensitive potassium (KATP) channels in the plasma membrane of the pancreatic beta cell.
More Information Supplier PageRapamycin (Sirolimus) prevents activation of T cells and B-cells by inhibiting their response to interleukin-2 (IL-2).
More Information Supplier Page
